鼓膜置管与鼓膜穿刺鼓室内注射类固醇的残余穿孔风险
本研究比较经鼓膜置管与鼓膜穿刺两种途径行鼓室内类固醇注射后残余鼓膜穿孔的风险。纳入18项研究共818耳及本地140耳队列进行荟萃分析,结果显示两种技术残余穿孔比例分别为1.11%和1.14%,无显著差异。
要点
- 经鼓膜置管注射类固醇不增加残余鼓膜穿孔风险。
- 两种途径残余穿孔率均较低,约1%左右。
- 临床可依据病情选择鼓膜置管或穿刺注射途径。
核心结论
- 经鼓膜置管行鼓室内类固醇治疗与经鼓膜穿刺注射相比,残余鼓膜穿孔风险无显著差异。
研究设计与样本
- 病例系列、系统综述与荟萃分析,纳入本地连续病例队列140耳及18项研究共818耳。
主要发现
- 经鼓膜置管组残余鼓膜穿孔比例为1.11%(95%CI 0.01%-3.27%)。
- 经鼓膜穿刺组残余鼓膜穿孔比例为1.14%(95%CI 0.028%-2.38%)。
- 两种技术间残余鼓膜穿孔风险无显著差异。
临床怎么用
- 鼓室内类固醇治疗时,经鼓膜置管途径不增加残余穿孔风险,可与穿刺注射途径同等选用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To investigate the risk of residual tympanic membrane (TM) perforation after intratympanic (IT) steroidal treatment administered via transtympanic injection compared with trans-tympanostomy tube (TyT). STUDY DESIGN: Case series, systematic review and meta analysis. METHODS: Data were retrieved from the medical files of an original cohort of all consecutive patients with sudden sensorineural hearing loss necessitating IT steroidal treatment in a tertiary medical center between January 1, 2016 and November 20, 2020. A systematic literature search of "MEDLINE" via "PubMed," "Embase," and "Web of Science" on comparable published cases was performed and meta-analysis was established. RESULTS: Eighteen studies describing 818 ears were included in the quantitative meta-analysis in addition to a local cohort of 140 ears. The proportion of residual TM perforation was 1.11% and 1.14% (95% confidence interval: 0.01%-3.27% and 0.028%-2.38%) in the TyT and trans-tympanic groups, respectively, suggesting no significant difference in residual TM perforation risk between these techniques. CONCLUSION: IT steroid therapy via trans-TyT is not associated with more residual perforations than IT steroid therapy via transtympanic injections. LEVEL OF EVIDENCE: NA Laryngoscope, 131:E2583-E2591, 2021.
引用
- Simani L, Shilo S, Oron Y, et al. Residual Perforation Risk Assessment of Intratympanic Steroids via Tympanostomy Tube Versus Transtympanic Injections. Laryngoscope. 2021. PMID: 34002883. doi:10.1002/lary.29609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。